- Sponsored Content
Adenovirus Vector Manufacturing Platform Using CIMmultus QA
December 1, 2021
20 Min View
Date: Dec 1, 2021
Duration: 20 Min
Sponsored by BIA Separations
This webcast features: Hana Jug, Project Manager in Process Development for Viral Vectors and Vaccines, BIA Separations
Downstream processing remains one of the main bottlenecks in Adenoviral vector manufacturing. At BIA Separations, a Sartorius company, we offer a platform for purification of Adenoviral vaccines using market leading CIM® monolithic chromatographic columns and an analytical toolbox for process monitoring in Adenoviral vaccine production.
Simplified purification of Adenovirus consists of typical downstream steps, including combined lysis, clarification, TFF and a chromatographic capture on pre-packed monolithic CIMmultus QA column.
TFF Retentate is prepared for chromatography with a fine filtration step to remove aggregates formed during TFF. Capture step using CIMmultus QA column is designed in bind-elute mode with salt gradient, to facilitate concentration of virus and removal of impurities. The in-process samples are analyzed using a high-throughput chromatographic approach on PAT fix HPLC system with analytical CIMac Adeno column. The analytical method was developed to track Adenovirus, control Adenovirus harvests, as well as follow the reduction of impurities through the manufacturing processes. Additional feature of such HPLC analytics is multi angle light scattering detector, which serves as orthogonal quantification method. Another important tool is PicoGreen fluorescence detection, very helpful when following the removal of chromatin and DNA residuals, known to cause side effects of vaccines.
During purification method development different materials were tested and compared in terms of purity and virus capacity. Working hand by hand with upstream turned out to be effective way for optimal process development.
List of takeaways:
CIMmultus QA is offering effective approach to tackle Adenovirus production bottlenecks, improve purity and quality of Adenovirus vaccines.
CIMmultus QA columns provide higher yields at lower manufacturing costs and are readily available, overcoming the shortage of raw material supply on the market.
Accompanying HPLC analytics using CIMac Adeno column is a reliable method offering rapid in-process insight for upstream and downstream applications.
Additional feature of HPLC analytics is multi angle light scattering detector, which serves as orthogonal quantification method and PicoGreen fluorescence detection, very helpful when following the removal of chromatin and DNA residuals, known to cause side effects of vaccines.
Robustness of developed process has been confirmed using various USP materials.
Just fill out the form below to watch the recorded webcast now.
Pfizer abandons $350m+ Seattle plant post-Seagen acquisitionMar 4, 2024|2 Min Read
Sarepta unfazed by Catalent’s acquisition by NovoMar 4, 2024|2 Min Read
Andelyn to make viral vectors in FNIH led gene therapy consortiumMar 1, 2024|1 Min Read
GLP-1 drug demand drives $250m fill/finish expansion for SimtraMar 1, 2024|3 Min Read
Mar 11 - Mar 14, 2024
Mar 11 - Mar 14, 2024
Accelerate speed to market for your next generation mAbs, vaccines, cell therapy, and gene therapy products. At the BioProcess International US West event in San Diego, CA, in March 2024 you can access today's innovative strategies and technologies designed to improve process efficiencies and maintain product quality across all phases of bioprocessing.Agenda